Follow The Filings

TWST position history

The shares of Twist Bioscience (TWST) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COMMON STOCK

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q2: 192,000 shares, $9.5M, 0.04% of portfolio, New
  2. 2024 Q3: 340,650 shares, $15M, 0.08% of portfolio, Add +77.4%
  3. 2024 Q4: 7,650 shares, $355K, <0.01% of portfolio, Reduce −97.8%
  4. 2025 Q1: 7,650 shares, $300K, <0.01% of portfolio
  5. 2025 Q2: 7,650 shares, $281K, <0.01% of portfolio
  6. 2025 Q3: 15,300 shares, $431K, <0.01% of portfolio, Add +100.0%
  7. 2025 Q4: 7,650 shares, $243K, <0.01% of portfolio, Reduce −50.0%
  8. 2026 Q1: 1,427,650 shares, $68M, 0.39% of portfolio, Add +18562.1%
  9. 2026 Q2: 2,136,400 shares, $220M, 1.0% of portfolio, Add +49.6%
  10. 2026 Q3: 2,136,400 shares, $413M, 1.8% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders